e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Lunchtime programme: of mice, man and cell cultures - discussing different approaches in experimental lung research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smoking mice – possibilities and limitations for studying COPD
G. Brusselle (Ghent, Belgium)
Source:
Annual Congress 2007 - Lunchtime programme: of mice, man and cell cultures - discussing different approaches in experimental lung research
Session:
Lunchtime programme: of mice, man and cell cultures - discussing different approaches in experimental lung research
Session type:
Symposium
Number:
3958
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Smoking mice – possibilities and limitations for studying COPD. Annual Congress 2007 - Lunchtime programme: of mice, man and cell cultures - discussing different approaches in experimental lung research
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018
Self-reported
vs.
observed functional limitations in COPD
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
The Scandinavian approach to using data for studying the early risks and consequences of asthma
Source: International Congress 2019 – How do big data and classical epidemiology contribute to solving chronic respiratory ill health?
Year: 2019
Genome-based risk prediction of asthma and COPD: applicability and psychological issues
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012
The effects of long-term smoking on pre-existing asthma in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 253s
Year: 2004
Answering questions and challenges in the management of health smoking and COPD patients
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients
Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases
Year: 2004
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Potential usefulness of phenotyping in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
COPD – future prospects for women
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006
Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011
COPD - Current challenges
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008
Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept